Production (Stage)
ProKidney Corp.
PROK
$0.9776
$0.190624.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.29% | 13.27% | -22.68% | -18.86% | -12.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.41% | 17.76% | -4.16% | 5.09% | 18.29% |
| Operating Income | -19.20% | -17.71% | 4.16% | -5.09% | -18.29% |
| Income Before Tax | -28.62% | -26.64% | 0.20% | -3.46% | -10.97% |
| Income Tax Expenses | -102.20% | -109.97% | -74.73% | 292.25% | 292.99% |
| Earnings from Continuing Operations | -23.97% | -20.59% | 1.24% | -5.58% | -13.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.07% | 2.17% | -10.85% | 6.21% | 46.37% |
| Net Income | -93.87% | -72.51% | -25.80% | -3.99% | 29.71% |
| EBIT | -19.20% | -17.71% | 4.16% | -5.09% | -18.29% |
| EBITDA | -18.51% | -17.10% | 5.23% | -4.34% | -17.97% |
| EPS Basic | -6.26% | -10.58% | 4.79% | -10.93% | -1,841.44% |
| Normalized Basic EPS | -104.46% | -78.28% | -44.51% | 23.53% | 422.00% |
| EPS Diluted | -6.26% | -10.58% | 4.79% | -10.93% | -1,841.44% |
| Normalized Diluted EPS | -104.46% | -78.28% | -44.51% | 23.53% | 422.00% |
| Average Basic Shares Outstanding | 84.25% | 56.59% | 30.48% | 4.59% | -32.83% |
| Average Diluted Shares Outstanding | 84.25% | 56.59% | 30.48% | 4.59% | -32.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |